228 related articles for article (PubMed ID: 8774099)
21. Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease.
Aleem FA; Predanic M
Fertil Steril; 1996 Mar; 65(3):510-6. PubMed ID: 8774278
[TBL] [Abstract][Full Text] [Related]
22. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovary syndrome.
Amin AF; Abd el-Aal DE; Darwish AM; Meki AR
Fertil Steril; 2003 Apr; 79(4):938-41. PubMed ID: 12749434
[TBL] [Abstract][Full Text] [Related]
24. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
25. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
[TBL] [Abstract][Full Text] [Related]
26. Impaired uterine perfusion associated with metabolic disorders in women with polycystic ovary syndrome.
Chekir C; Nakatsuka M; Kamada Y; Noguchi S; Sasaki A; Hiramatsu Y
Acta Obstet Gynecol Scand; 2005 Feb; 84(2):189-95. PubMed ID: 15683382
[TBL] [Abstract][Full Text] [Related]
27. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].
Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620
[TBL] [Abstract][Full Text] [Related]
28. L-arginine plus drospirenone-ethinyl estradiol in the treatment of patients with PCOS: a prospective, placebo controlled, randomised, pilot study.
Battaglia C; Mancini F; Battaglia B; Facchinetti F; Artini PG; Venturoli S
Gynecol Endocrinol; 2010 Dec; 26(12):861-8. PubMed ID: 20642382
[TBL] [Abstract][Full Text] [Related]
29. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
30. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
[TBL] [Abstract][Full Text] [Related]
31. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
Słopień R; Lewandowski K; Kolacz E; Zawilska K; Warenik-Szymankiewicz A
Gynecol Endocrinol; 2006 Nov; 22(11):651-4. PubMed ID: 17145652
[TBL] [Abstract][Full Text] [Related]
32. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
33. Ultrasonography of the ovaries and its correlation with clinical and endocrine parameters in infertile women with PCOS.
Sikka P; Gainder S; Dhaliwal LK; Bagga R; Sialy R; Sahdev S
Int J Fertil Womens Med; 2007; 52(1):41-7. PubMed ID: 17987887
[TBL] [Abstract][Full Text] [Related]
34. Menstrual cycle-related morphometric and vascular modifications of the clitoris.
Battaglia C; Nappi RE; Mancini F; Cianciosi A; Persico N; Busacchi P; Facchinetti F; de Aloysio D
J Sex Med; 2008 Dec; 5(12):2853-61. PubMed ID: 18761595
[TBL] [Abstract][Full Text] [Related]
35. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
36. Blood flow changes in the ovarian and uterine arteries during the normal menstrual cycle.
Tan SL; Zaidi J; Campbell S; Doyle P; Collins W
Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):625-31. PubMed ID: 8828425
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
[TBL] [Abstract][Full Text] [Related]
38. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
39. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
[TBL] [Abstract][Full Text] [Related]
40. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
